Drug Shortage Report for MYOCHRYSINE
Report ID | 14864 |
Drug Identification Number | 01927620 |
Brand name | MYOCHRYSINE |
Common or Proper name | Myochrysine |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GOLD SODIUM THIOMALATE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 5 |
ATC code | M01CB |
ATC description | SPECIFIC ANTIRHEUMATIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2017-07-07 |
Actual start date | 2017-07-07 |
Estimated end date | |
Actual end date | 2017-08-03 |
Shortage status | Resolved |
Updated date | 2017-08-04 |
Company comments | Manufacturing Delay |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-08-04 | English | Compare |
v5 | 2017-08-03 | French | Compare |
v4 | 2017-08-03 | English | Compare |
v3 | 2017-07-08 | English | Compare |
v2 | 2017-07-06 | French | Compare |
v1 | 2017-07-06 | English | Compare |
Showing 1 to 6 of 6